Sidewinder Therapeutics Company
Sidewinder Therapeutics develops bispecific antibody-drug conjugates (ADCs) aimed at treating solid tumors. Their mission is to create life-saving therapies through precision therapeutics.
Last Funding Date:
2026-04-08
Total Funding:
137000000
Founded Date:
2023-01-01
Headquarters:
San Diego,California,United States,North America
Funding Status:
private
Industry:
Quantum Biology
Super Industry:
Quantum Science Applications
Funding Stage:
Early Stage Venture
Funding Total Value:
137000000
Last Funding Total Usd:
137000000
Last Funding Total Currency:
USD
Last Funding Total Value:
137000000
Founders:
Eric Murphy,Ryan Corcoran